Maximizing Value for Scientific and Medical Affairs
Satya Sagi, commented, “We are very thrilled to partner with Joe Pierce and his EndPoint team. By forming SciMax Global, I believe we have established a powerful combination of exceptional people, strategy, and solutions from both sides to address key challenges in Medical Affairs.”
MIRAMAR BEACH, Fla., and PRINCETON, N.J. (PRWEB)
August 03, 2020
Techsol Corporation and EndPoint Technolgoies announced today that both companies have joined forces to form SciMax Global, a new subsidiary company that focuses on providing next-generation technology platform services and value-driven business consulting services for the digital transformation of Scientific Communications and Medical Affairs in the pharmaceutical industry.
With the formation of SciMax Global, Joe Pierce, Founder and President of EndPoint Technologies and Satya Sagi, Founder and CEO of Techsol Corporation along with key team members from both companies have come together to combine the Medical Affairs technology prowess of Techsol and the consulting expertise of EndPoint.
SciMax Global will focus exclusively on Medical Affairs, a third strategic pillar of the new age Pharmaceutical organization, alongside R&D and Commercial. To address key Medical Affairs business challenges for global pharmaceutical and life sciences companies, the company will offer value-driven solutions through 2 broad service categories:
SciMax Consulting Services
- Subject Matter Expertise to develop and execute Medical Affairs Digital Transformation Strategy utilizing Artificial Intelligence, Analytics, Validation, Compliance, Data Privacy, Strategy and Project Management
SciMax Medical Affairs Platform Services
- Unified Cloud Solution for Pharma to support Medical Affairs Programs such as Medical Information, Grants, Publications, Investigator Initiated Studies (IIS/IIT), Expanded Access etc
- Collaboration and Engagement Portals (Med Info, HCP, Patient etc.), Real World Evidence Data Analytics Outcome Assessments
The core SciMax Medical Affairs Technology Platform shall include Techsol’s MedInquirer (MIQ), a leading cloud-based, Medical Information, and Medical Communication System along with the MIQ Self Service Portal and MIQ Mobile App. For more than 5 years, MedInquirer has been used by Global Biopharma Companies and Contact Centers to efficiently, respond to Medical Information Inquiries and to report and triage Adverse Events and Product Complaints. Techsol Corporation first developed MedInquirer in a strategic partnership with one of the largest, US Contact Centers and a top-ten, international, specialty Pharmaceutical Company. SciMax will continue to develop Artificial Intelligence (AI) based solutions, congress technology and conduct MI-Tech Forum events.
Joe Pierce, says, “I’ve been in the industry for nearly 25 years and Techsol’s MedInquirer is simply the best MI solution available. As EndPoint has continued to expand our professional services, we wanted to be able to bring forward and support the best MI solution to the marketplace. This can be achieved now as SciMax. We are extremely excited to be partnering with Sagi and the Techsol team to continue to develop, implement, and support this comprehensive solution.”
Satya Sagi, commented, “We are very thrilled to partner with Joe Pierce and his EndPoint team. By forming SciMax Global, I believe we have established a powerful combination of exceptional people, strategy, and solutions from both sides to address key challenges in Medical Affairs. We have positioned the SciMax platform to become a market leader through our deep domain expertise, industry relationships, continuous technology innovation, consulting capability and strong commitment to the Pharmaceutical Industry.”
Joe Pierce shall be the Chief Executive Officer (CEO) of SciMax Global. He will lead the strategy formation and execution for the new company. All the team members of EndPoint have joined the SciMax team in various strategic roles. Saad Rahman, previously the Director of Product Management of MedInquirer, shall now assume the role of Chief Product Officer (CPO) to lead the technology platform strategy, development, and delivery. Other team members of Techsol will be involved in administrative, business, development, quality assurance, service and support roles. Sagi will continue as Founder and CEO of Techsol Corporation. As a founding board member of SciMax, he will continue to support the executive team in shaping the overall platform strategy and process execution.
About SciMax Global
SciMax Global is an innovative Scientific Communications and Medical Affairs technology solutions provider in the pharmaceutical industry. With a unified cloud Technology Platform and value-driven Consulting Services, SciMax has proven capabilities to help Pharma and Life Science companies for managing different medical affairs programs that improve patient outcomes and care excellence through automation, evidence and insights generation.
Contact
Joe Pierce
CEO, SciMax Global
+1 630-204-2652
joe.pierce@scimaxglobal.com
101 College Rd East Princeton 08540 NJ
http://www.scimaxglobal.com
About Techsol Corporation
Techsol Corporation specializes in offering cloud-based, information technology services and innovative software solutions to global pharmaceutical, life sciences and healthcare companies. Founded in 2010, a market leader in providing highly configurable process-oriented technology solutions for digitally transforming pharmaceutical business operations across medical affairs, clinical development and drug safety. With offices in Princeton, NJ/ Hyderabad, India/ Seoul, South Korea, Techsol Corporation delivers domain-specific business solutions focused on establishing cross-platform integrations, business process automation, facilitating stakeholder collaboration, risk-based validation, and providing operational insights with advanced AI and data analytics.
About EndPoint Technologies
EndPoint Technologies is dedicated to providing comprehensive technology and business consulting services to life science organizations. Specializing in Medical Affairs in Pharmaceutical and Biotech Companies, EndPoint provides insight and assistance with the process of selecting and implementing new technology, including strategic planning, requirement definition, project management, solutions evaluation, implementation, validation, and training. EndPoint has extensive experience in providing solutions around data privacy, helping companies become and remain compliant. In addition, EndPoint provides systems management, maintenance, and support for a number of widely used software solutions.
Share article on social media or email: